SIGMA-ALDRICH search Sigma-Aldrich MKI67 products
includes other brands or spellings
|
| ih | | Sigma MKI67 antibody was tested in immunohistochemistry by Human Protein Atlas. |
EMD BIOSCIENCES search EMD Biosciences MKI67 products
includes other brands or spellings
|
| flow | | Oncogene Research Products KI67 antibody was used in western blot to study p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific MKI67 products
includes other brands or spellings
|
| ih | | NeoMarkers monoclonal Ki-67 (MB67) antibody was used in immunohistochemistry to study the expression of MMP-9 and TIMP-1 in gastric carcinoma. |
| ih | | NeoMarkers anti-Ki-67 antibody was used in immunohistochemistry to study platelet-derived serotonin involved in the initiation of liver regeneration. |
BECKMAN COULTER search Beckman Coulter MKI67 products
includes other brands or spellings
|
| flow | | DakoCytomation Ki-67 (MIB-1) –FITC was used in flow cytometry to analyze the expression of Ki-67 in the basal cells isolated from the basal epithelium of human prostatic tissue. |
| ic | | Dako rabbit anti-Ki67 polyclonal antibody was used in immunocytochemistry to study the human gastrointestinal cancers suppressor activity of 15-PGDH induced by TGF-β. |
| ih | | DakoCytomation MKI67 antibody was tested in immunohistochemistry by HPA (HPA001164) . |
| ih | | Immunotech mouse monoclonal anti-MIB-1 antibody was used in immunohistochemistry to study GnT-V expression in non-small cell lung cancers. |
| ih | | DAKO anti-human Ki-67 antibody was used in immunohistochemistry to study the clinical significance and the involvement of APC in tumorigenesis. |
| ih | | DAKOCytomation mouse monoclonal anti-Ki67 antibody was used in immunohistochemistry to study the interaction of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas. |
| ih | | DAKO monoclonal antibody for Ki-67 (clone MIB1) was used in immunohistochemistry to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. |
| ih | | Dako A/S polyclonal rabbit Ki-67 antibody was used in immunohistochemistry to study the PTEN and p27 expression level during tumor cell proliferation. |
| ih | | Dako anti-Ki-67 antibody was used in immunohistochemistry to study the relationship of ARHI expression to the progression of breast cancer. |
| ih | | Dako monoclonal anti-Ki-67 antibody was used in paraffin sections from human normal 、pathological breast tissue and in immunohistochemistry to study the fuction of HMGA1 protein expression for the diagnosis and prognosis of human breast cancer. |
| ih | | DAKO rabbit anti-human Ki-67 antibody was used in paraffin sections from human urothelial bladder carcinomas and in immunohistochemistry to study the role of TIMP-2 in human urothelial cancer. |
| ih | | Dako anti-Ki67 antibody was used in immunohistochemistry to detect Ki67 in invasive lobular carcinoma breast tumor sections. |
| ih | | DAKO mouse monoclonal antihuman Ki-67 antigen (clone MIB-1) was used in immunocytochemistry to detect the localization of Ki-67 in invasive ductal carcinoma with actively proliferating neoplastic cells from human mammary gland. |
| ih | | DAKO anti-Ki-67 monoclonal antibody was used in immunohistochemistry to detect the expression of Ki-67 in tumor cells from patients with non-small-cell lung cancer (NSCLC). |
| ih | | Dako mouse monoclonal anti-Ki-67 antibody (clone Mib-1) was used in paraffin sections from human cancer and in immunohistochemistry to study the effect of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. |
| ih | | Dako anti-Ki67 antibody was used in immunohistochemistry to detect Ki67 in adjacent serial sections of two breast invasive ductal carcinomas from patients. |
| ih | | Dako anti-Ki-67 antibody was used in paraffin sections from human hepatocellular tumors and in immunohistochemistry to study the role of mTOR and S6K in hepatocellular carcinoma. |
| ih | | DAKO anti-Ki67 antibody was used in immunohistochemistry to detect Ki67 in normal lung, benign lesions, preinvasive lesions, low-grade tumors and invasive lung carcinoma. |
| ih | | DAKO polyclonal anti-Ki-67 antibody was used in immunohistochemistry to detect Ki-67 in intra-tumoral and peri-tumoral lymphatic vessels of patients. |
| ih | | Immunotech antibody against MIB-1 was used in immunohistochemstry to detect MIB-1 expression in human oligodendroglial tumors. |
| ih | | Immunotech anti-Ki67 antibody (clone MIB-1) was used in tissue sections from human and in immunohistochemistry to study the cell cycle regulation in patients with IM at the GOJ. |
| ih | | Immunotech International monoclonal antibody Ki-67 (MIB-1) was used in immunohistochemistry to study the inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. |
| ih | | Immunotech anti-MIB-1 antibody (MIB-1) was used in immunohistochemistry to study the implications of expression of a panel of oncogenic proteins (Bcl-2, Bcl-6, and c-Myc) and p53 for predicting clinical outcome, particularly overall survival, in immunocompetent individuals with primary CNS DLBCL. |
| ih | | Immunotech Ki-67 antibody (MIB-1) was used in immunohistochemistry to study the resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. |
| ih | | DAKO monoclonal anti-Ki67 antibody (clone MIB-1) was used in immunohistochemistry to study the reduced dystroglycan expression in human breast and colon cancers and the possible association with tumor progression. |
| ih | | DAKO mouse monoclonal antihuman Ki-67 IgG was used in immunohistochemistry to study the possible spatial and temporal relationships among GATA-6 expression, cell proliferation, apoptosis, and the apoptosis-related proteins Bcl-2 and Bax during human fetal testicular development. |
| ih | | Dako Cytomation monoclonal proliferation-associated nuclear antigen antibody (MIB-1) was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. |
| ih | | DAKO anti-Ki-67 (MIB-1) antibody was used in immunohistochemistry to study expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. |
| ih | | DAKO mouse monoclonal anti-Ki-67 (clone MIB-1) antibody was used in immunohistochemistry to study expression of Mina53 in human colon cancer. |
| ih | | DAKO A/S mouse monoclonal anti-Ki-67 (clone MIB-1) antibody was used in immunohistochemistry to study expression of Mina53 in in ESCC cell. |
| ih | | Dakopatts anti-Ki67 antibody was used in immunohistochemistry to study role of Artemis in the NHEJ pathway of DNA repair and lymphocyte immunodeficiency. |
| ih | | DAKO monoclonal anti-Ki67 antibody MIB1 was used in immunohistochemistry to study the steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. |
| ih | | Coulter murine anti–Ki-67 antibody was used in immunohistochemistry to study the expression of CDK2, KAP, and HTm4 in human tissues by seeing staining pattern of Ki-67, a nuclear cell proliferation-associated antigen, expressed in all active stages of the cell cycle. |
| wb | | Dako monoclonal anti-Ki67 antibody (clone Ki-67) was used in protein from human prostate and in western blot to study the expression of EG-VEGF/PK1 and PK2 and their receptors (PK-R1 and PK-R2) in human prostate and their involvement in cancer. |
BIOGENEX search Biogenex MKI67 products
includes other brands or spellings
|
| ic | | BioGenex anti-Ki-67 antibody was used in normal human diploid fibroblasts (NHDFs) and in immunocytochemistry to study the effect of p73 on retinoblastoma (RB) tumor suppressor pathway. |
| ih | | BioGenex Ki-67 antibody was used in immunohistochemistry to study its expression in granular cell tumor. |
| ih | | BioGenex mouse monoclonal anti-Ki67 antibody (clone MIB-1) was used in immunohistochemistry to study nuclear localization of KLF4 in early-stage breast cancer. |
| wb | | Biogenex monoclonal anti-Ki67 antibody was used in western blot to study the localization of phosphorylated BRCA1. |
DAKO CYTOMATION A/S
|
| ih | | Dako Cytomation A/S monoclonal anti-Ki-67 antibody (clone MIB 1) was used in paraffin sections from human tumors and immunohistochemistry to study the role of activated Akt expression in prognosis of pancreatic ductal adenocarcinoma. |
DAKO CYTOMATION DK
|
| ih | | Dako Cytomation DK anti-Ki67 antibody Mib1 was used in immunohistochemistry to study the relationship of DMBT1 expression to breast cancer. |
DAKOCYTOMATION NORDEN A/S
|
| ih, wb | | DakoCytomation Norden A/S mouse monoclonal anti-Ki-67 antibody MIB1 was used in western blot and immunohistochemistry to study the expression of ADAM12 in human glioblastomas and its association with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. |
NOVOCASTRA
|
| ih | | Novocastra monoclonal mouse anti-Ki67 was used in immunohistochemistry to detect the localization of Ki67 in human placenta during normal pregnancy. |
| ih | | Novocastra anti-Ki67 antibody was used in immunohistochemistry to study E-catenin connects cell-density–dependent adherens junctions with the developmental hedgehog pathway. |
Articles Reviewed |
| 1. José L Donato et al. Human HTm4 is a hematopoietic cell cycle regulator. 2002 |
| 2. Eva Röijer et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. 2002 |
| 3. Masahide Ikeguchi et al. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. 2002 |
| 4. Oddbjørn Straume et al. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. 2003 |
| 5. Chung-Che Chang et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. 2003 |
| 6. Despina Moshous et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. 2003 |
| 7. Thorsten Stiewe et al. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. 2003 |
| 8. Alessandro Sgambato et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. 2003 |
| 9. Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 |
| 10. Ilkka Ketola et al. Transcription factor GATA-6, cell proliferation, apoptosis, and apoptosis-related proteins Bcl-2 and Bax in human fetal testis. 2003 |
| 11. Ole J Halvorsen et al. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. 2003 |
| 12. Sheng Zhang et al. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. 2003 |
| 13. Andrea Decensi et al. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. 2003 |
| 14. F Pizzagalli et al. Identification of steroid sulfate transport processes in the human mammary gland. 2003 |
| 15. Lin Wang et al. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. 2003 |
| 16. Louise S Villadsen et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. 2003 |
| 17. N J Trudgill et al. Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction. 2003 |
| 18. Hariklia Gakiopoulou et al. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. 2003 |
| 19. Kwesi Teye et al. Increased expression of a Myc target gene Mina53 in human colon cancer. 2004 |
| 20. T Yoshida et al. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. 2004 |
| 21. Hirotoshi Dosaka-Akita et al. Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers. 2004 |
| 22. Ashka Y Pandya et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. 2004 |
| 23. Julien Mazieres et al. Loss of RhoB expression in human lung cancer progression. 2004 |
| 24. Shinji Yamamoto et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. 2004 |
| 25. Hideaki Yokoo et al. Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. 2004 |
| 26. Brian H Le et al. Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation. 2004 |
| 27. Gavin D Richardson et al. CD133, a novel marker for human prostatic epithelial stem cells. 2004 |
| 28. Takashi Suzuki et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. 2004 |
| 29. P Braidotti et al. DMBT1 expression is down-regulated in breast cancer. 2004 |
| 30. Majida Esslimani-Sahla et al. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. 2004 |
| 31. Hiroki Utsunomiya et al. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. 2004 |
| 32. Daniel G Hayward et al. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. 2004 |
| 33. Takahide Kodama et al. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. 2004 |
| 34. Makoto Tsuneoka et al. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. 2004 |
| 35. Gennaro Chiappetta et al. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 2004 |
| 36. Min Yan et al. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. 2004 |
| 37. Elisabeth D Coene et al. Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. 2005 |
| 38. Fikret Sahin et al. mTOR and P70 S6 kinase expression in primary liver neoplasms. 2004 |
| 39. Gita Ohlsson et al. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. 2005 |
| 40. Kwang-Hwa Park et al. Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships. 2005 |
| 41. Mark W Jackson et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. 2005 |
| 42. Wen-Hui Lien et al. alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. 2006 |
| 43. Mickael Lesurtel et al. Platelet-derived serotonin mediates liver regeneration. 2006 |
| 44. Alexandra Gellhaus et al. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. 2006 |
| 45. Daniela Pasquali et al. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. 2006 |
| 46. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |